Agenzia Italiana del Farmaco
Direct communication with healthcare professionals on Voxzogo®️ (vosoritide) - Direct communication with healthcare professionals on Voxzogo®️ (vosoritide)
Direct communication with healthcare professionals on Voxzogo®️ (vosoritide)
Voxzogo® (vosoritide): change to administration syringe and needle leading to product administration in Units (U) instead of mL.
Summary
- From July 2023, Voxzogo co-packs will contain new solvent needles and new administration syringes due to supply chain reasons.
- The new solvent needle has an alternative safety mechanism with an activated safety shield cover (see Table 1).
- The new administration syringe has Units (U) graduation markings( typically used for insulin products and sometimes referred to as Insulin Units) instead of mL graduation markings (see Table 1).
- It is important that you explain to your patient or the caregiver the recommended dose to be delivered with the new syringe, as the units of measure are not 1:1. For example, 0.1 mL is equivalent to 10 U. Please see Table 2 for the conversion of single dose volumes from mL to U.
- There are no changes to the Voxzogo dosage or volume. Recommendations for use remain unchanged.
- The product information has been amended to reflect the use of new needles and syringes.
Published on: 04 September 2023
È iniziato il conto alla rovescia per la #MedSafetyWeek di quest'anno ⏱️
🔗 Clicca sul link in bio p...
Vai al post →
📆 Dalla prossima settimana unisciti a noi per la decima edizione della #MedSafetyWeek!
🌎 118 Paes...
Vai al post →
🤝 Incontro istituzionale tra il Presidente di #AIFA Robert Nisticò e il Capo dell’Autorità Egiziana...
Vai al post →
🤝 Ad Amsterdam l’incontro istituzionale tra #AIFA e Taiwan FDA.
📚 Durante il Summit 2025 della Co...
Vai al post →
Ciprofloxacina, levofloxacina, moxifloxacina: nomi forse poco familiari, ma che indicano una classe ...
Vai al post →
📊 Online il Rapporto AIFA 2024
La pubblicazione presenta i dati e le attività principali del 2024 a...
Vai al post →
